- Home
- RNXT vs PWM Comparison
RNXT vs PWM Comparison
Compare RNXT & PWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- PWM
- Stock Information
- Founded
- RNXT 2012
- PWM 2018
- Country
- RNXT United States
- PWM Hong Kong
- Employees
- RNXT N/A
- PWM N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- PWM
- Sector
- RNXT Health Care
- PWM
- Exchange
- RNXT Nasdaq
- PWM Nasdaq
- Market Cap
- RNXT 44.6M
- PWM 12.4M
- IPO Year
- RNXT 2021
- PWM 2023
- Fundamental
- Price
- RNXT $1.26
- PWM $0.59
- Analyst Decision
- RNXT Strong Buy
- PWM
- Analyst Count
- RNXT 2
- PWM 0
- Target Price
- RNXT $7.50
- PWM N/A
- AVG Volume (30 Days)
- RNXT 648.4K
- PWM 344.1K
- Earning Date
- RNXT 11-12-2025
- PWM 02-13-2026
- Dividend Yield
- RNXT N/A
- PWM N/A
- EPS Growth
- RNXT N/A
- PWM N/A
- EPS
- RNXT N/A
- PWM N/A
- Revenue
- RNXT $662,000.00
- PWM $639,912.00
- Revenue This Year
- RNXT $2,895.35
- PWM N/A
- Revenue Next Year
- RNXT $313.04
- PWM N/A
- P/E Ratio
- RNXT N/A
- PWM N/A
- Revenue Growth
- RNXT N/A
- PWM 83.60
- 52 Week Low
- RNXT $0.75
- PWM $0.31
- 52 Week High
- RNXT $1.69
- PWM $2.70
- Technical
- Relative Strength Index (RSI)
- RNXT 58.65
- PWM 62.46
- Support Level
- RNXT $1.19
- PWM $0.51
- Resistance Level
- RNXT $1.45
- PWM $0.58
- Average True Range (ATR)
- RNXT 0.12
- PWM 0.06
- MACD
- RNXT 0.02
- PWM -0.00
- Stochastic Oscillator
- RNXT 62.75
- PWM 54.85
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.